Oriental Moon Tree Limited, a holding company based in the British Virgin Islands, has filed a Schedule 13D with the United States Securities and Exchange Commission (SEC) detailing its substantial ownership in Garden Stage Limited. The filing, dated October 11, 2024, indicates that Oriental Moon Tree Limited holds a 67.84% stake in Garden Stage, which is equivalent to 10,600,000 shares. This ownership level is based on the 15,625,000 outstanding shares of Garden Stage's common stock as reported in the issuer’s prospectus filed on August 28, 2024. The document outlines that Oriental Moon Tree Limited has been actively selling shares of Garden Stage in the open market, with transactions recorded between August 23, 2024, and October 10, 2024. The sales occurred at various prices, with the largest transactions of 200,000 shares each...Show More

Oriental Moon Tree Limited, a holding company based in the British Virgin Islands, has filed a Schedule 13D with the United States Securities and Exchange Commission (SEC) detailing its substantial ownership in Garden Stage Limited. The filing, dated October 11, 2024, indicates that Oriental Moon Tree Limited holds a 67.84% stake in Garden Stage, which is equivalent to 10,600,000 shares. This ownership level is based on the 15,625,000 outstanding shares of Garden Stage's common stock as reported in the issuer’s prospectus filed on August 28, 2024. The document outlines that Oriental Moon Tree Limited has been actively selling shares of Garden Stage in the open market, with transactions recorded between August 23, 2024, and October 10, 2024. The sales occurred at various prices, with the largest transactions of 200,000 shares each taking place on October 4 and October 10, 2024, at prices of $2.21 and $1.75 respectively. The filing also states that Oriental Moon Tree Limited may review its investment strategy in the future and take appropriate actions regarding its stake in Garden Stage. No plans or proposals were disclosed that would result in major corporate changes such as mergers, asset sales, changes in board or management, capitalization changes, or other significant corporate restructurings.